| Literature DB >> 27793270 |
Abdulwahab Abuderman1, Mohammed Abbas2.
Abstract
BACKGROUND: Since the majority of morphological changes evaluation of myocardium in ischaemic heart disease was in animal model, we detected the importance to evaluate such changes in human patients to gain insights into the targets of cellular damage and to reconcile or refine those experiments.Entities:
Keywords: Cardiomyocyte; Left atrial appendage; Myocardial capillaries; ischaemic heart disease
Mesh:
Year: 2016 PMID: 27793270 PMCID: PMC6139875 DOI: 10.1016/j.bj.2016.08.002
Source DB: PubMed Journal: Biomed J ISSN: 2319-4170 Impact factor: 4.910
Light microscopic pathology of the myocardial microvasculature and cardiomyocyte in control subjects and patients with IHD.
| Parameters | Controls | IHD | |
|---|---|---|---|
| Arteriole density | 30.8 ± 2.5 | 29.5 ± 1.3 | 0.58 |
| Venule density | 31.8 ± 2.1 | 30.0 ± 1.2 | 0.41 |
| Intermediate vessel density | 61.8 ± 3.8 | 58.0 ± 3.0 | 0.49 |
| Capillary density | 341.7 ± 17.1 | 376.3 ± 9.9 | 0.06 |
| Total vessel density | 446 ± 22.4 | 493.8 ± 12.9 | 0.18 |
| Arteriole W/L ratio | 8.3 ± 1.6 | 18.6 ± 2.9 | 0.000 |
| Venule W/L ratio | 1.4 ± 0.3 | 0.9 ± 0.1 | 0.43 |
| Cardiomyocyte diameter | 27.4 ± 0.8 | 26.8 ± 0.4 | 0.45 |
Mean ± standard error, vascular density (no.mm−2), W/L ratio = Wall to lumen ratio.
Correlation between vascular density and cardiomyocyte diameter in IHD patients.
| Art. density | Venule density | Inter- mediate vessel density | Capillary density | Total vessel density | |
|---|---|---|---|---|---|
| Cardio- myocyte diameter | R = −0.34 | R = −0.23 | R = −0.14 | R = −0.3 | R = −0.32 |
P = P-value, R = Correlation coefficient.
Electron microscopic pathology of myocardial capillaries in control subjects and IHD patients.
| Parameter | Controls | IHD | |
|---|---|---|---|
| Lumen area | 20.9 ± 1.2 | 14.9 ± 0.1 | 0.00 |
| Basement membrane area | 3.7 ± 0.2 | 4.0 ± 0.1 | 0.39 |
| Vessel area | 49.7 ± 2.2 | 46.3 ± 1.5 | 0.2 |
| Endothelial area | 18.2 ± 1.1 | 21.4 ± 1.2 | 0.1 |
| Endothelial cell profile no. | 4.1 ± 0.1 | 3.9 ± 0.1 | 0.14 |
| Endothelial nuclear no. | 0.6 ± 0.1 | 0.7 ± 0.1 | 0.43 |
| Pericyte area | 6.8 ± 0.7 | 6.1 ± 0.5 | 0.45 |
| Pericyte nuclear no. | 0.24 ± 0.1 | 0.13 ± 0.06 | 0.07 |
Mean ± standard error.
Fig. 3Changes in myocardial capillary pericyte area and number of pericyte nuclei between control subjects and IHD patients.
Patients’ demographic data.
| Demographic data | Control | IHD |
|---|---|---|
| Number | 22 | 53 |
| Age | 61.6 ± 2.9 | 65.46 ± 1.4 |
| Gender (M:F) | 11:11 | 41:12 |
| Body Mass Index | 26.6 ± 1.2 | 27.2 ± 0.5 |
| Hypertension | 7 (31.8) | 32 (60.4) |
| Hyperlipidemia | 13 (59.1) | 45 (84.9) |
| Smoker | 15 (68.2) | 41 (77.4) |
| Atrial Fibrillation | 12 (54.5) | 20 (37.7) |
| Myocardial Infarction | 0 | 34 (64.2) |
| CVD 1 | 0 | 3 (5.7) |
| CVD 2 | 0 | 8 (15.1) |
| CVD 3 | 0 | 42 (79.3) |
| No Angina | 4 | 0 |
| Angina Symptoms G1 | 12 (54.5) | 9 (16.9) |
| Angina Symptoms G2 | 5 (22.7) | 17 (32.1) |
| Angina Symptoms G3 | 1 (4.6) | 27 (50.9) |
| Angina Symptoms G4 | 0 | 0 |
| β-blocker | 4 (18.2) | 43 (81.1) |
| Diabetes | 0 | 0 |
Mean ± standard error, No (%), G = Grade, CVD = Coronary Vessel Disease, IHD = ischaemic Heart Disease.